-
1 Comment
Harbin Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 4.6% below its 200 day moving average.
From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Harbin Pharmaceutical Group Co., Ltd's total revenue sank by 6.6% to $3B since the same quarter in the previous year.
Its net income has dropped by 1467.5% to $-705M since the same quarter in the previous year.
Finally, its free cash flow fell by 367.0% to $-709M since the same quarter in the previous year.
Based on the above factors, Harbin Pharmaceutical Group Co., Ltd gets an overall score of 1/5.
Exchange | SHG |
---|---|
CurrencyCode | CNY |
ISIN | CNE0000009T3 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Beta | 0.12 |
---|---|
Market Cap | 9B |
PE Ratio | 15.42 |
Target Price | 22.12 |
Dividend Yield | None |
Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese medicines, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, recombinant human erythropoietin injections, ibuprofen granules, iron vitamin B12 oral solutions, ceftriaxone sodium injections, pediatric acetaminophen granules, Jiananxi Vitapak nutrition packages, lacidipine tablets, roxatidine acetate hydrochloride for injections, and penicillin and cephalosporin antibiotic preparations. The company sells its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. It is also involved in culture, science and technology, passenger transport, food, property, security, and pharmaceutical investment services, as well as biology and health technology activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600664.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025